Validcare sits between #biotech and #biopharma sponsors, investors, investigators, participants/patients and regulators providing an interesting Vantage point on clinical research. We believe the clinical trial process can be simplified. We work diligently to optimize the planning and execution of clinical trials for our clients -- whether we or another stakeholder controls the outcome. And there are lots of areas for improvement for all of us! Often times the planning starts with fund raising. Today, we are happy to share the first in a series of insights from our CEO, Patrick McCarthy, Esq. , where he shares best practices observed at JPM2025 by sponsors raising capital. Going forward watch for more insights on how the planning and execution of clinical trials can be improved. NEWSFLASH: Real improvement requires more than technology -- It means we have to CHANGE! Or at least that's Validcare's Vantage Point! What is yours? Let us know if you have specific areas of improvement for #clinicaltrials to be addressed. #biopharma #clinicaloperations #biotech #clinicalstudies #meddevice
Will 2025 finally open the flood gates for investments in emerging #biotech and #biopharma? As an investor and service provider to the segment, I share my insights from over 50 meetings at @JPM2025. #clinicalresearch #clinicaltrials #venturecapital #investment #healthcareinvestment CSSi LifeSciences